Email not displaying correctly? View it in your browser.
NCDR

 

 
February/March 2013

In This Issue:

headline 1NCDR.13
headline 1NCDR’s ACC.13 Abstract Guide
headline 1CathPCI Registry Heart Article
headline 1ACC.13
headline 1New Joint Yale-ACC Research Project
headline 1PCI Readmission

 

  NCDR 
   

NCDR.13 Is This Week!

Still haven’t registered to attend NCDR.13 from March 7-8? Onsite registration begins on Wednesday, March 6, 2013 at 5:00 p.m., and will be allowed only as space permits.

As an NCDR.13 attendee, you should already have received an email that gives you access to an electronic syllabus, or “eSyllabus”. Using the link, you will be able to access important meeting information and all session PowerPoints. If you haven’t received the eSyllabus email yet, please contact NCDR at (800) 257-4737 or ncdr@acc.org.

Each year, NCDR professionals showcase their registry innovations through poster presentations displayed during the NCDR Annual Conference. Posters provide other attendees with real-life success stories and best practices, helping to foster ideas and provide action steps for improvements that can be applied in their hospitals. This year the NCDR has received the most submissions to date with over 25 posters. Also a first for NCDR.13 an overall People’s Choice award will be presented to the authors of the poster receiving the highest number of votes from all NCDR.13 attendees. Please visit the NCDR Annual Conference page for more information.


 

NCDR Research to be Highlighted at ACC.13

Twenty-two abstracts based on data from the NCDR® will be presented during ACC.13 and TCT@ACC.i2 in San Francisco, March 9-11. Research from six registries, including the NCDR’s practice-based registry, the PINNACLE Registry® will be featured. Five are oral presentations, and 17 are scientific posters.

Review the complete NCDR Abstract Guide, which lists the date, time and location of each presentation. If you will be on-site during the sessions, we invite you to stop by the ACC booth #S2032, to learn more about NCDR research and pick up a printed copy of the guide.

 The NCDR congratulates Jonathan Hsu, MD author of the poster “Inappropriate Oral Anticoagulant Use in Atrial Fibrillation Patients with a Low Risk of Thromboembolism: Insights from the NCDR® PINNACLE Program”, which is being recognized as a Best of Poster and Best FIT Poster at ACC.13. The poster will be on display Monday, March 11th from 9:45-10:30 a.m. in Poster Sessions, Expo North.

In addition to demonstrating the importance of registries and their contribution to lifesaving cardiovascular research, scientific abstracts showcase the NCDR’s role in advancing cardiovascular clinical practice and patient outcomes. To learn more, visit the NCDR Research page.

 

Attend NCDR’s Theater Presentations during ACC.13

Don’t forget to attend NCDR theater presentations, at the ACC booth #S2032, while attending ACC.13. Here’s a sneak peek at the topics that will be presented:

  • PINNACLE Registry®: Growing in Size and Growing in Value

  • Surviving MI

  • Best Practices in Quality Improvement

  • NCDR Physician Dashboard: A Link to MOC Part IV Credit
    For more information please visit www.ncdr.com/acc.13
    for more...


 

Overview of CathPCI Registry® Shows Valuable Data Collection

An article published on January 15, 2013 in Heart highlights the ways the CathPCI Registry has expanded beyond its primary purpose of characterizing the quality of care provided to patients undergoing angiography and PCI to serve as a platform for quality improvement.

According to the article, not only are states and payers employing the CathPCI Registry as part of broad quality programs, researchers are using data from the registry for cutting-edge health services research. In addition, the roles of the registry are expanding even further, "extending to postmarket device surveillance, education, multicentered interventional research and international collaborations."


ACC.13

ACC.13 and TCT@ACC-i2 will be taking place over the course of three days, March 9 – 11, 2013, in San Francisco focusing on the transformation of cardiovascular care — from discovery to delivery. While at ACC.13, you’ll have opportunities to engage in one of 16 educational pathways, see the latest in emerging science and network with your colleagues.

Learn about new discoveries and research, advance your understanding of new techniques and medicines, and focus on improving care and preventing cardiovascular disease in your patients. Hear breaking news on the important research trials and guideline updates, find out what you need to know about health care reform — and how it’s all going to impact your patients.

The science presented at ACC.13 will significantly impact the practice of medical care for physicians and patients around the world. ACC.13 will have global impact with more than 300 media members from around the world expected in San Francisco, and more than 1.5 billion media impressions anticipated!

ACC.13 will provide you with abundant opportunities for networking including:

  • More opportunities to interact before, during and after the meeting

  • Engaging, interactive education sessions

  • Forums for global collaboration and cooperation to improve cardiovascular care worldwide

  • Exchanges with colleagues with similar clinical, geographic or educational interests

For more information on ACC.13, please visit the ACC.13 homepage


New Joint Yale & ACC Research Project

Percutaneous coronary intervention (PCI) is one of the most frequently performed cardiovascular interventions in the United States. Studies show that risk-standardized PCI outcomes vary significantly across hospitals. Among Medicare patients, 30-day readmission rates range from 7.5 to 16.2% and 30-day mortality rates for patients with STEMI or cardiogenic shock range from 8.6 to 16.9%. With public reporting of PCI outcomes expected in the near future, clinicians and hospitals need to understand the factors that distinguish high and low performing hospitals.

To address this gap in knowledge, researchers from Yale University and the American College of Cardiology are collaborating on the TOP PCI study. The first phase of the study, which began in 2010, consisted of in-depth analysis of interviews with more than 200 staff members at 13 high and low performing PCI hospitals. The information has been used to identify the hospital culture, organizational structure, and processes that may impact PCI outcomes.

This knowledge is now being applied in the second phase of the study − a web-based survey of 500 hospitals randomly selected from the CathPCI Registry®. The survey will capture how hospitals structure and deliver care to PCI patients, and will identify the strategies associated with better outcomes. The ultimate goal of the study is to provide hospitals with tools they can use to improve performance.

 Participating hospitals will receive a summary of this work, including aggregate data regarding national patterns of PCI care. In addition, the knowledge generated through this work will provide the opportunity to:

  • Apply best-practices in your hospital

  • Discover new ways to use your hospital’s CathPCI Registry data

  • Identify strategies to prepare for the release of the publicly-reported measures

To learn more about this exciting initiative, visit www.ncdr.com/toppci. To find out if your hospital has been selected to participate, email Marcia.Mulligan@yale.edu or call (203) 737-6114.


ACC, CMS and Yale Launch Voluntary Public Reporting Effort for PCI Readmissions

This spring, hospitals participating in the CathPCI Registry will have the opportunity to review and voluntarily report their results on the 30-day risk-standardized Percutaneous Coronary Intervention (PCI) readmission measure. Hospitals that choose to participate in this effort will have their readmission rates posted on Medicare’s Hospital Compare website. The ACC developed this measure in collaboration with the Yale New Haven Health Services Corporation - Center for Outcomes Research and Evaluation (YNHHSC/CORE) using rigorous scientific methodology. The measure, which is supported by the Centers for Medicare and Medicaid Services (CMS) and endorsed by the National Quality Forum (NQF), uses methodology that is consistent with the methods used to identify unplanned readmissions in the CMS measures currently reported on Hospital Compare for acute myocardial infarction, heart failure and pneumonia. However, this measure uses data from the CathPCI Registry for risk adjustment.

This voluntary hospital public reporting pilot leverages the existing infrastructure of the registries and tests the usefulness and feasibility of providing this additional quality information to the public. The effort is consistent with the ACC’s public reporting policy. The College has been engaged in the development and refinement of this measure from the very beginning to ensure its scientific validity and usability.

How Hospitals Can Participate

CathPCI Registry-participating hospitals will receive their measure results and the data used to calculate their measure scores in a confidential hospital-specific report posted privately on the NCDR report Dashboard starting the week of March 18. NCDR hospitals are encouraged to take part in this program by reviewing their reports and agreeing to have their data publicly reported on Hospital Compare by April 19. Learn more about how your hospital can participate in voluntary public reporting at www.ncdr.com/pcireadmission.


The Latest Research from the NCDR®

The following papers based on NCDR registry data were recently published:

ACTION Registry®-GWTGTM
Association of chronic lung disease with treatments and outcomes patients with acute myocardial infarction. American Heart Journal

Care Registry™
Outcomes of Carotid Endarterectomy in the Elderly: Report From the National Cardiovascular Data Registry. Stroke

Carotid Artery Stenting of a Contralateral Occlusion and In-Hospital Outcomes Results From the CARE Registry. JACC: Cardiovascular Interventions

ICD RegistryTM
Survival of Patients Receiving a Primary Prevention Implantable Cardioverter-Defibrillator in Clinical Practice vs Clinical Trials. JAMA

To learn more about NCDR research, visit http://www.ncdr.com/webncdr/research/ and join the NCDR Research Network group on LinkedIn.

 

NCDR Statistics

CathPCI Registry®

 

 

 

 

header

To prevent mailbox filters from deleting your NCDR communications, add ncdr@acc.org to your address book.

To view this message online please click here.


B13043